The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis.

The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis.

Item
http://www.wikidata.org/entity/Q27852950
EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancerCIViC databaseUnravelling signal escape through maintained EGFR activation in advanced non-small cell lung cancer (NSCLC): new treatment optionsMeta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs.Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy.Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).RNA-Seq and Network Analysis Revealed Interacting Pathways in TGF-β-Treated Lung Cancer Cell Lines.Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR.A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal transition.The prognostic role of pretreatment epidermal growth factor receptor T790M mutation in advanced non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR MutationPrecision medicine: hype or hoax?Epidermal growth factor receptor T790M mutation as a prognostic factor in EGFR-mutant non-small cell lung cancer patients that acquired resistance to EGFR tyrosine kinase inhibitors.The alteration of T790M between 19 del and L858R in NSCLC in the course of EGFR-TKIs therapy: a literature-based pooled analysis.The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer
P2860

The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis.

Item
http://www.wikidata.org/entity/Q27852950
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The predictive role of pretrea ...... cer patients: a meta-analysis.
@ast
The predictive role of pretrea ...... cer patients: a meta-analysis.
@en
The predictive role of pretrea ...... cer patients: a meta-analysis.
@nl
type
label
The predictive role of pretrea ...... cer patients: a meta-analysis.
@ast
The predictive role of pretrea ...... cer patients: a meta-analysis.
@en
The predictive role of pretrea ...... cer patients: a meta-analysis.
@nl
altLabel
The predictive role of pretrea ...... ncer patients: a meta-analysis
@en
prefLabel
The predictive role of pretrea ...... cer patients: a meta-analysis.
@ast
The predictive role of pretrea ...... cer patients: a meta-analysis.
@en
The predictive role of pretrea ...... cer patients: a meta-analysis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P478
P577
P698
P921
P932
P3181
P356
P1433
P1476
The predictive role of pretrea ...... cer patients: a meta-analysis.
@en
P2093
P2860
P304
P31
P3181
P356
P407
P478
P577
P698
P921
P932